Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613001070729Phase 3Completed
Phase 3, open-label, single-arm trial of mitomycin c in caustic esophageal stricture, sponsored by Ain Shams University. Primary endpoint: Percentage of patients with resolution of dysphagia. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613001070729.